Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
However, it might not work as well as the approved versions and can be less safe due to issues like uneven mixing of ingredients, wrong doses, and unproven dosage forms
The SURPASS-2 trial (Fras et al., 2021, New England Journal of Medicine) provided the first head-to-head comparison of Tirzepatide against semaglutide 1mg in adults with type 2 diabetes
Weight loss varies from person to person and also depends on lifestyle factors such as diet and exercise
You are not becoming "frail"
Warnings Do not exceed recommended serving
The new vials are priced at a 50% or greater discount in comparison to other incretin (GLP-1) medications for obesity, thereby offering a more affordable option for patients
US$ 28.47
US$ 24.54
US$ 29.88
US$ 25.87
US$ 20.34
US$ 27.42
US$ 21.08
US$ 27.34
US$ 24.51
